Your browser doesn't support javascript.
loading
Dyslipoproteinemia in murine systemic lupus erythematosus.
Jacobson, M S; Trachtman, H; Feldman, J; Samuel, P; Ilowite, N T.
Affiliation
  • Jacobson MS; Department of Pediatrics, State University of New York Stony Brook.
Atherosclerosis ; 79(2-3): 205-11, 1989 Oct.
Article in En | MEDLINE | ID: mdl-2597228
ABSTRACT
Dyslipoproteinemia, a feature of systemic lupus erythematosus may contribute to premature atherosclerosis. In order to develop an experimental model for this dyslipoproteinemia we measured plasma concentrations of lipoproteins in juvenile NZB/W (lupus) and NZB/B (control) mice. Additionally to evaluate the effects of a diet rich in n - 3 fatty acids we measured lipoprotein concentrations in mice on normal or menhaden oil-enriched diets. The lupus mice had elevated triglycerides compared to the controls, similar to that seen in human SLE patients (161 +/- 31 vs 113 +/- 13 mg/dl, P less than 0.003). In contrast, the menhaden oil diet fed NZB/W mice had triglycerides similar to the NZB/B control fed group. In the NZB/W murine SLE model, dyslipoproteinemia is an early sign of disease as has been shown in man, therefore this model will be useful in elucidating the mechanism of dyslipoproteinemia in SLE.
Subject(s)
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Lipidoses / Lipoid Proteinosis of Urbach and Wiethe / Lupus Erythematosus, Systemic Limits: Animals Language: En Journal: Atherosclerosis Year: 1989 Type: Article
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Lipidoses / Lipoid Proteinosis of Urbach and Wiethe / Lupus Erythematosus, Systemic Limits: Animals Language: En Journal: Atherosclerosis Year: 1989 Type: Article